Microbial diagnostics and wellness product developer uBiome has received series C funding in a Dentsu Ventures-backed round.

US-based microbial genomics technology developer uBiome has raised $83m in series C funding from investors including Dentsu Ventures, the corporate venturing vehicle formed by marketing firm Dentsu. The round was led by venture capital fund OS Fund and included 8VC, Y Combinator and undisclosed new and existing investors. It increased the company’s funding to altogether.…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.